TY - JOUR
T1 - Physical and psychological health among breast cancer survivors
T2 - Interactions with sedentary behavior and physical activity
AU - Trinh, Linda
AU - Amireault, Steve
AU - Lacombe, Jason
AU - Sabiston, Catherine M.
N1 - Publisher Copyright:
Copyright © 2015 John Wiley & Sons, Ltd.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Background Reducing sedentary behavior (SED) may be one promising strategy to reduce treatment-related side effects in breast cancer given the unique health benefits distinct from the beneficial effects of moderate-to-vigorous intensity physical activity (MVPA). Objectives To examine the associations between SED and the late-effects symptoms of pain, fatigue, and depression among breast cancer survivors (BCS), and the interactive associations between SED, light PA, and MVPA on these symptoms. Methods One hundred and ninety-five BCS provided baseline data 3 to 4 months post-systemic treatment, as part of the Life After Breast Cancer: Moving On longitudinal study. Pain, fatigue, and depression symptoms were assessed using validated self-report questionnaires. Objective measures of MVPA, light PA, and SED (i.e. sitting time) were assessed by accelerometers over the same period. Self-reported demographic and medical variables were collected. Results In hierarchical multiple regression analyses, the interaction effect of MVPA by SED was significantly associated with pain (p=.02), fatigue (p=.01), and depression (p=.006). Follow-up simple slope analyses demonstrated that among BCS with lower levels of MVPA, higher levels of SED significantly predicted higher levels of fatigue (p<.001), higher levels of pain (p=.06), and higher levels of depression (p=.08). Conclusions SED was associated with higher levels of fatigue, pain, and depression in BCS, and was more pronounced among those with lower levels of MVPA. However, SED was not associated with these symptoms among BCS with higher levels of MVPA. Pairing health promotion messages to reduce SED and increase MVPA are likely to result in better symptom management.
AB - Background Reducing sedentary behavior (SED) may be one promising strategy to reduce treatment-related side effects in breast cancer given the unique health benefits distinct from the beneficial effects of moderate-to-vigorous intensity physical activity (MVPA). Objectives To examine the associations between SED and the late-effects symptoms of pain, fatigue, and depression among breast cancer survivors (BCS), and the interactive associations between SED, light PA, and MVPA on these symptoms. Methods One hundred and ninety-five BCS provided baseline data 3 to 4 months post-systemic treatment, as part of the Life After Breast Cancer: Moving On longitudinal study. Pain, fatigue, and depression symptoms were assessed using validated self-report questionnaires. Objective measures of MVPA, light PA, and SED (i.e. sitting time) were assessed by accelerometers over the same period. Self-reported demographic and medical variables were collected. Results In hierarchical multiple regression analyses, the interaction effect of MVPA by SED was significantly associated with pain (p=.02), fatigue (p=.01), and depression (p=.006). Follow-up simple slope analyses demonstrated that among BCS with lower levels of MVPA, higher levels of SED significantly predicted higher levels of fatigue (p<.001), higher levels of pain (p=.06), and higher levels of depression (p=.08). Conclusions SED was associated with higher levels of fatigue, pain, and depression in BCS, and was more pronounced among those with lower levels of MVPA. However, SED was not associated with these symptoms among BCS with higher levels of MVPA. Pairing health promotion messages to reduce SED and increase MVPA are likely to result in better symptom management.
UR - http://www.scopus.com/inward/record.url?scp=84943816708&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943816708&partnerID=8YFLogxK
U2 - 10.1002/pon.3872
DO - 10.1002/pon.3872
M3 - Article
C2 - 29978929
AN - SCOPUS:84943816708
SN - 1057-9249
VL - 24
SP - 1279
EP - 1285
JO - Psycho-Oncology
JF - Psycho-Oncology
IS - 10
ER -